Neubase Therapeutics Inc. (NBSE)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 0 $0 -100% 0%
2.
Greenlight Capital

David Einhorn

0 $0 -100% 0%
3.
Springbok Capital

Gavin Saitowitz And Cisco J. Del Valle

0 $0 -100% 0%
4. 0 $0 -100% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$0.98 61,076 Large Shareholder 680,081 2023-09-01 Filing
$1.92 6,200 Officer 11,200 2022-03-30 Filing
$1.81 10,000 Officer 30,000 2022-03-18 Filing
$1.74 10,000 Officer 20,000 2022-03-17 Filing
$1.62 10,000 Officer 10,000 2022-03-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.19 50,000 Large Shareholder 0 2023-09-18 Filing
$1.26 103,337 Large Shareholder 50,000 2023-09-15 Filing
$1.44 129,108 Large Shareholder 153,337 2023-09-14 Filing
$1.44 3,376 Large Shareholder 472,926 2023-09-11 Filing
$1.53 128,847 Large Shareholder 476,302 2023-09-08 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 65,724 $48,635 0%
2. 46,970 $34,762 0.04%
3. 21,083 $15,604 0%
4. 18,981 $14,048 0%
5. 16,476 $12,194 0%
News See All